✦ LIBER ✦

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK1 receptor antagonist

✍ Scribed by Rocco Cirillo; Mara Astolfi; Bruno Conte; Giuseppe Lopez; Massimo Parlani; Rosa Terracciano; Christopher I Fincham; Stefano Manzini

Book ID: 119414270
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 187 KB
Volume: 341
Category: Article
ISSN: 0014-2999
DOI: 10.1016/s0014-2999(97)01453-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of MEN 11467: a potent new

Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK1 receptor antagonist

✍ R. Cirillo; M. Astolfi; B. Conte; G. Lopez; M. Parlani; G. Sacco; R. Terracciano 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 183 KB

MEN10,627: A potent and selective NK2 ta

MEN10,627: A potent and selective NK2 tachykinin receptor antagonist in the human isolated bronchus

✍ M. Astolfi; S. Treggiari; S. Manzini 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Discovery of a New Series of Potent and

Discovery of a New Series of Potent and Selective Linear Tachykinin NK 2 Receptor Antagonists

✍ Fedi, Valentina; Altamura, Maria; Catalioto, Rose-Marie; Giannotti, Danilo; Giol 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 300 KB

MEN 11420, a potent and selective tachyk

MEN 11420, a potent and selective tachykinin NK2 receptor antagonist in the guinea-pig and human colon

✍ Paolo Santicioli; Sandro Giuliani; Riccardo Patacchini; Manuela Tramontana; Marc 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 186 KB

Biochemical and pharmacological activiti

Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist

✍ X Emonds-Alt; C Advenier; C Cognon; T Croci; S Daoul; J.P Ducoux; M Landi; E Nal 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 975 KB

The airways pharmacology of DNK333, a po

The airways pharmacology of DNK333, a potent, selective, non-peptide dual NK1/NK2 receptor antagonist

✍ C.A. Lewis; A.Z. El-Hashim; M. Gerspacher; K. Hoshiko; L. Mazzoni; H.-J. Pfannku 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

## Abstract The airways' pharmacology of DNK333 ((1R,3R,2E)‐N‐[3,4‐dichlorobenzyl)]‐4‐[(hexahydro‐2‐oxo‐1H‐azepin‐3‐yl)amino]‐N‐methyl‐3,5bis(trifluoromethyl) benzamide), a potent and selective dual NK~1~/NK~2~ neurokinin receptor antagonist is described in the present paper. DNK333 bound with high